Key Account Manager, London And South East

Key Account Manager, London And South East

The Key Account Manager (KAM) is a field-based expert, that strategically drives the commercial objectives of Alnylam's hereditary transthyretin amyloidosis (hTTR) portfolio. The KAM will be accountable for developing and implementing key account plans in their designated territory to optimize care for patients. The Key Account Manager, reporting to the Sales Director, is expected to develop territory specific strategic account plans in the context of the overall product strategy and in close alignment and collaboration with functions of Medical Affairs, Patient Advocacy, Market Access and Commercial, while ensuring full compliance with the relevant company, industry, legal, regulatory and ethical standards.

Summary of Key Responsibilities

• Present a positive image of the company and develop awareness of hTTR and Alnylam's RNAi platform with relevant groups of healthcare professionals
• Develop, own, and drive territory and account plans, including customer targeting and cycle plan, in line with Marketing strategy and Business Operations guidance
• Promote our product portfolio and achieve post-launch KPIs
• Perform a detailed analysis of the assigned territory to identify, assess, and support the development of relevant centres for diagnosis and referral of appropriate patients to the specialist treatment centres
• Support awareness of patient identification, diagnostic testing and referral pathways by executing against a territory strategy and account specific plans
• Build relationships and maintain contact with key customers and provide commercial and scientific services to ensure access at site of care where appropriate
• Manage and execute local meetings to drive diagnosis and referral, in collaboration with the Medical Affairs Team for physicians and other healthcare professionals
• Lead and co-ordinate key projects and signature initiatives as requested on behalf of the wider sales team
• Represent Alnylam at local and national meetings and congresses
• Manage and coordinate the Alnylam relationship with relevant professional bodies as assigned
• Serve as the communication link between key customers and internal teams
• Support more junior members of the KAM team in their development through coaching and sharing of best practice
• Liaise and collaborate with relevant internal staff (Medical Affairs, Commercial Leads, Marketing and Business Operations Manager), as required
• Ensure that all customer and environmental insights are communicated promptly to the relevant functions such as Marketing, Market Access or the TTR Leadership Team
• Timely and accurate reporting and continuous diligent maintenance of the CRM database
• Conduct all activities to highest ethical standards in accordance with country code of practice and local Laws and regulations
• Significant domestic travel and occasional international travel as needed

Qualifications

• In depth sales experience in bio/pharmaceutical sales and Key Account Management experience, in the orphan or ultra-orphan market
• Ability to gain consistent access and develop strong & professional relationships for product promotion with healthcare providers in reference centers and the community
• Effective communication and influencing skills to engage with professionals at all organizational levels
• Strong business acumen to add value to the existing health care structures.
• Ability to draw on previous experiences and insights to generate and maintain appropriate awareness and timely access to treatment
• Ability to travel within a territory on a regular basis and must hold a valid driver's licence
• Excellent organisational skills

Alnylam Pharmaceuticals is an EEO employer committed to an exciting, diverse, and enriching work environment.

Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.